JSC Avexima supports young scientists

As part of its program to support young scientists, JSC Avexima served as a partner for the IV All-Russian Conference Viral Infections  -  From Diagnosis to Clinic, which took place on April 13–14, 2023, at the A.A. Smorodintsev Research Institute of Influenza of the Russian Ministry of Health in St. Petersburg.

The conference brought together students, postgraduate researchers, and young scientists from leading research, educational, and clinical institutions in St. Petersburg, Moscow, Novosibirsk, Tomsk, and Yekaterinburg.

The event featured presentations on the latest developments and research in fundamental and applied virology, including the epidemiology, diagnosis, treatment, and prevention of viral infections, including COVID-19.

JSC Avexima, the manufacturer of the antiviral drug Nobazit® for the treatment of acute respiratory viral infections (ARVI), influenza, and COVID-19, traditionally supports advanced scientific research in virology and aids young scientists by facilitating the multifaceted exchange of new data.